Literature DB >> 24956283

Silencing of murine transthyretin and retinol binding protein genes has distinct and shared behavioral and neuropathologic effects.

J N Buxbaum1, A J Roberts2, A Adame3, E Masliah4.   

Abstract

The murine genes encoding transthyretin (TTR) and retinol binding protein (RBP) were independently silenced by targeted disruption more than 10 years ago. Studies of both strains showed surprisingly little impact on either thyroid function or retinoid metabolism. Silencing TTR led to a relatively mild behavioral phenotype. In order to gain insight into the behavioral effect and determine if it was related to TTR's function as the carrier of RBP we carried out simultaneous studies with homozygous Rbp4(-/-) and Ttr(-/-) animals 4-7 months of age. Both strains showed behavioral differences relative to Ttr and Rbp4 wild-type animals and each other. The patterns were discrete for each knockout although there was some overlap. Neuropathologic examination of the cortex and hippocampus revealed cortical and hippocampal (CA3) neuronal loss in both and some degree of gliosis, more pronounced in the Rbp4(-/-) mice. There also appeared to be a major reduction in proliferating neuroblasts in the subventricular zone in both strains, which was also more severe in the Rbp4(-/-) mice. This is the first description of behavioral abnormalities in Rbp4(-/-)mice. The data also indicate that it is unlikely that the behaviors seen in Ttr(-/-) mice are related to its function as an RBP carrier.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  behavior; neuronal loss; neuropathology; retinol binding proteins; transthyretin

Mesh:

Substances:

Year:  2014        PMID: 24956283     DOI: 10.1016/j.neuroscience.2014.06.019

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  Liver-secreted RBP4 does not impair glucose homeostasis in mice.

Authors:  Ronja Fedders; Matthias Muenzner; Pamela Weber; Manuela Sommerfeld; Miriam Knauer; Sarah Kedziora; Naomi Kast; Steffi Heidenreich; Jens Raila; Stefan Weger; Andrea Henze; Michael Schupp
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

2.  Evidence From Human Placenta, Endoplasmic Reticulum-Stressed Trophoblasts, and Transgenic Mice Links Transthyretin Proteinopathy to Preeclampsia.

Authors:  Shibin Cheng; Zheping Huang; Sayani Banerjee; Sukanta Jash; Joel N Buxbaum; Surendra Sharma
Journal:  Hypertension       Date:  2022-05-24       Impact factor: 9.897

Review 3.  Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.

Authors:  Joel N Buxbaum; Frederick L Ruberg
Journal:  Genet Med       Date:  2017-01-19       Impact factor: 8.822

4.  RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers.

Authors:  Kyong Nyon Nam; Anais Mounier; Nicholas F Fitz; Cody Wolfe; Jonathan Schug; Iliya Lefterov; Radosveta Koldamova
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

5.  Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.

Authors:  Nádia Pereira Gonçalves; João Moreira; Diana Martins; Paulo Vieira; Laura Obici; Giampaolo Merlini; Margarida Saraiva; Maria João Saraiva
Journal:  J Neuroinflammation       Date:  2017-06-06       Impact factor: 8.322

Review 6.  Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Aβ in the Central Nervous System.

Authors:  Joel N Buxbaum; Jan Johansson
Journal:  Front Neurosci       Date:  2017-03-15       Impact factor: 4.677

7.  Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Alexander Nørgård Alsing; Jonas Ellegaard Nielsen; Shona Pedersen; Svend Kirkeby; Bent Honoré; Henrik Vorum
Journal:  Mol Vis       Date:  2018-11-26       Impact factor: 2.367

8.  Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia.

Authors:  J R Gomes; R S Nogueira; M Vieira; S D Santos; J P Ferraz-Nogueira; J B Relvas; M J Saraiva
Journal:  Cell Death Differ       Date:  2016-08-12       Impact factor: 15.828

9.  Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.

Authors:  M A Frye; M Nassan; G D Jenkins; S Kung; M Veldic; B A Palmer; S E Feeder; S J Tye; D S Choi; J M Biernacka
Journal:  Transl Psychiatry       Date:  2015-12-08       Impact factor: 6.222

10.  The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.

Authors:  Daniel R Jacobson; Alice A Alexander; Clement Tagoe; W T Garvey; Scott M Williams; Sara Tishkoff; David Modiano; Sodiomon B Sirima; Issa Kalidi; Amadou Toure; Joel N Buxbaum
Journal:  Mol Genet Genomic Med       Date:  2016-07-14       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.